BioPharma Reporter

APRIL 22, 2024

Ahead of CPHI North America, we caught up with Lisa Stiles, director, business development at Selkirk Pharma, an exhibitor at the event, to find out how the CMO is navigating regulatory changes, challenges and more.

Business Development 98

Business Development Marketing Development Contract Manufacturing 98

Pharmaceutical Technology

SEPTEMBER 15, 2022

The increase in the production of biological drugs such as vaccines, gene and cell therapies, and monoclonal antibodies, is increasing the volume of injectable drug products in the global healthcare market. Discover the top commercial dose injectables companies in contract marketing.

Marketing 100

Marketing Containment Production Sales 100

Pharmaceutical Technology

SEPTEMBER 20, 2022

Contract marketing companies support pharmaceutical companies in creating, improving, and maintaining their brand, as well as reducing risk, and ensuring better product placement in the market. Identifying the top commercial dose (non-sterile) companies in contract marketing.

Marketing 100

Marketing Drug Delivery Systems Production Containment 100

Pharmaceutical Technology

SEPTEMBER 8, 2022

Increasing drug failure rates and essential drug shortages have driven the growth of the compounding pharmacies market, which has a high growth potential, especially in emerging economies. Discover the top pharmaceutical compounding companies in contract marketing. Test method development. . Test method development.

Marketing 100

Marketing Pharmacy Containment Sales 100

Pharmaceutical Technology

FEBRUARY 1, 2023

We believe that the combination of these expected near-term launches, additional pipeline products that could potentially come to market in the medium-term, and anticipated contributions from business development, has the potential to set the company up for continued robust growth through the rest of this decade and beyond.”

Business Development 261

Business Development Production Marketing Development 261

pharmaphorum

AUGUST 8, 2022

As we reported this morning, the deal gives Pfizer already-approved SCD therapy Oxbryta (voxelator) – which industry watchers reckon could see a dramatic uptick in sales with Pfizer’s marketing muscle – plus a phase 3 antibody candidate, a phase 1 follow-up to Oxbryta that could offer improved dosing.

Marketing 111

Marketing Sales Gene Editing Antibody 111

Pharmaceutical Technology

SEPTEMBER 14, 2022

More than 100 approved peptide-based therapeutics are currently available in the market. The increasing demand for API peptide products is in turn increasing the demand for peptide API manufacturers who also offer contract marketing services. Discover the top API protein and peptide companies in contract marketing.

Protein 100

Protein Marketing Manufacturing Reagent 100

Pharmaceutical Technology

SEPTEMBER 8, 2022

Pharmaceutical solid dose manufacturing companies in contract marketing segment have gained a vital position in pharmaceutical formulations. Find the leading pharmaceutical solid dose manufacturing companies in contract marketing.

Manufacturing 100

Manufacturing Marketing Contract Manufacturing Containment 100

BioPharma Reporter

MARCH 14, 2022

Pfizer Inc says it will maintain its supply of medicines to Russia but it will not initiate new clinical trials in the country, while Bayer is suspending investment projects and new-business development in that market.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Business Development 105

BioTech 365

JANUARY 27, 2022

Mainz Biomed Appoints Steve Quinn as VP Business Development Mainz Biomed Appoints Steve Quinn as VP Business Development Highly experienced diagnostics business development executive appointed to lead growth initiatives across international markets and drive international sales of ColoAlert at-home screening … Continue reading →

Business Development 40

Business Development Development Sales Marketing 40

Crucial Data Soutions

JUNE 27, 2022

After experiencing significant growth in the clinical trial solutions market in 2021, Crucial Data Solutions has added another industry veteran to its leadership team. Founded in 2010, Crucial Data Solutions (CDS) provides the most innovative low-code/no-code data and clinical trial management technology on the market today.

Business Development 52

Business Development Development Clinical Trials Clinical Trials 52

BioTech 365

OCTOBER 14, 2020

Expanded leadership team will drive new business opportunities to support the company’s go-to-market strategies ROSEVILLE, Minn.–(BUSINESS –(BUSINESS WIRE)–Calyxt, Inc. In this role, … Continue reading →

Business Development 40

Business Development Development Marketing 40

FDA Law Blog

SEPTEMBER 26, 2023

(HP&M), a leader in providing legal and regulatory support to the life sciences industries, today announced the appointment of Jeff Grizzel to the newly created position of Chief Marketing Officer (CMO). Jeff joins HP&M from Compliance Architects where he served as Vice President of Business Development.

Marketing 59

Marketing Life Science Business Development Compliance 59

Pharmaceutical Technology

MAY 29, 2023

FivepHusion has collaborated with Treehill Partners and Syneos Health to strategically progress development and commercialisation of its chemotherapeutic formulation Deflexifol in markets across the globe. Syneos will support the commercialisation and clinical development capabilities of FivepHusion.

Business Development 130

Business Development Development Clinical Development Marketing 130

Pharmaceutical Technology

AUGUST 30, 2022

Zerion Pharma has entered a partnership with Insud Pharma for the development and marketing of drug products using Zerion Pharma's solubility-boosting Dispersome technology. . Under the deal, Zerion will handle the development of Dispersome formulations of marketed drugs.

Development 130

Development Drugs Bioavailability Production 130

Pharmaceutical Technology

JULY 1, 2022

The funding will offer capital to extend Blueprint’s varied pipeline toward marketing as well as to continue seeking strategic and synergistic business development prospects. The company noted that the deal will bring substantial non-dilutive, low-cost capital to boost innovation and growth.

Medicine 147

Medicine Business Development Sales Life Science 147

Pharmaceutical Technology

JULY 29, 2022

The most common marketed drugs in this space aim to address the hyperammonaemia caused by the defective genes in this disorder. Drugs for dialysis, amino acid supplements, and drugs which convert blood ammonia are marketed right now as the go-to urea cycle disorder treatments. Future Possibilities.

RNA 245

RNA Gene Expression Gene Gene Therapy 245

BioSpace

JUNE 29, 2022

billion to expand Blueprint's pipeline and pursue business development opportunities. Blueprint Medicines announced strategic financing collaborations with Sixth Street and Royalty Pharma for up to $1.25

Marketing 60

Marketing Business Development Medicine Development 60

Camargo

SEPTEMBER 23, 2020

Thomas Kassberg, Chief Business Officer, Ultragenyx. Often, only the first treatment available will make it to the market given the small patient populations, so it is important for developing partners to understand fully the natural history of disease progression, the indication, and the current standard of care.

Business Development 136

Business Development Drugs Development Production 136

Drug Patent Watch

DECEMBER 10, 2024

Their collaborative approach and access to specialized equipment and facilities make them an invaluable partner for companies seeking to bring new products to market. CDMOs and How They Support Business Development. References: Ellis, J. 2023, November 17). link] Societal CDMO. 2023, October 12). Societal CDMO.

Compliance 98

Compliance Manufacturing Production Regulation 98

Drug Channels

MARCH 11, 2022

Today’s guest post comes from Stacey Little, Senior Vice President of Business Development and Marketing at AssistRx. Stacey analyzes trends in patient support services and reimbursement hubs. Click here to schedule your meeting.

Pharmacy 97

Pharmacy Business Development Drugs Marketing 97

Pharmaceutical Technology

SEPTEMBER 7, 2022

The growing prevalence of chronic diseases and rising geriatric population has led to increasing demand for advanced medication adherence systems, personalised healthcare, and mobile health systems, which are the major driving factors for the patient adherence market. Discover the leading patient adherence pharmaceutical companies.

Pharmacy 130

Pharmacy Containment Manufacturing Compliance 130

Pharmaceutical Technology

MAY 5, 2023

Hasten also purchased Rocephin’s marketing authorisation and intellectual property including trademarks. This investment helped the firm to support the business development of its pipeline assets. Hasten Biopharmaceutic has purchased the commercial rights for Rocephin in mainland China from Swiss healthcare firm Roche.

Business Development 130

Business Development Marketing Development 130

Drug Channels

MARCH 10, 2023

Today’s guest post comes from Stacey Little, Senior Vice President of Business Development and Marketing at AssistRx. Stacey discusses digital hubs and the affordability advantages they offer both patients on specialty therapies and their health care providers.

Pharmacy 98

Pharmacy Business Development Drugs Marketing 98

Pharmaceutical Technology

SEPTEMBER 6, 2022

The growing need for better pharmaceutical logistics, the rising demand for fast-track support, as well as growing adoption of telematics in pharmaceutical logistics are some of the important factors that are expected to drive the pharmaceutical logistics market. Finding the top pharmaceutical logistics and pharma supply chain companies.

Containment 147

Containment Pharmacy Life Science Production 147

Pharmaceutical Technology

MARCH 10, 2023

The pharmaceutical freeze-drying systems market is expected to be driven by the integration of smarter technologies in lyophilisation methods such as electron microscopy, biochemistry, and advancement in surgeries.

Manufacturing 147

Manufacturing Production Containment Antibody 147

Pharmaceutical Technology

JULY 14, 2022

The commercial investment required to research and develop an innovative drug, prove its safety and efficacy, and bring it to market is staggering. Go-to-market strategies. The challenge of providing adequate access to the peripheral EU markets is quite evident. Efforts have been made to change this.

Drugs 147

Drugs Medicine Marketing Development 147

XTalks

JANUARY 17, 2024

Monogram is focused on developing patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. Ben is an engineer by training and before joining Monogram, he served as the Director of Business Development at Pro-Dex, an OEM manufacturer of Orthopedic Robotic End-Effectors.

Life Science 115

Life Science Engineer Business Development Development 115

pharmaphorum

OCTOBER 1, 2021

It has made Oxford Nanopore’s chief executive and cofounder Gordon Sanghera an on-paper fortune of £63 million, while another cofounder – chief business development officer Spike Willcocks – is now worth £30 million. The post Oxford Nanopore makes stellar debut on UK stock market appeared first on.

Marketing 52

Marketing Genomics Genome Business Development 52

Fierce Pharma

OCTOBER 17, 2024

and Europe.

Licensing 67

Licensing Licensing Business Development Marketing 67

Pharmaceutical Technology

SEPTEMBER 5, 2022

Wholesale pharmaceutical companies also offer services such as end formulation contracts, which help pharmaceutical marketing companies and pharmacies locate manufacturing units across regions and coordinate negotiations when required. Discover the top pharmaceutical wholesalers.

Packaging 130

Packaging Packaging Compliance Manufacturing 130

BioPharma Reporter

NOVEMBER 21, 2023

OSP was delighted to talk to Vetterâs Carsten Press, a senior leader of the global sales organization, and business development among many operational functions.

Branding 84

Branding Business Development Sales Development 84

Delveinsight

SEPTEMBER 8, 2021

There are several challenges faced by any company entering or persisting in the market, few of which are managerial, statistical, financial, and analytical decisions to be made by a client organization for which they would require people possessing more knowledge in the specified field that can serve as an advantage.

Marketing 52

Marketing Production Sales Life Science 52

XTalks

DECEMBER 8, 2021

Growing Sugar Substitute Market. According to MarketsandMarkets , the global sugar substitute market was worth an estimated $16.5 The growth of the market can be attributed to an increase in health consciousness among consumers and an increased demand for better-for-you alternatives. Sweet, in the same press release.

Branding 121

Branding Manufacturing Marketing Production 121

pharmaphorum

NOVEMBER 7, 2022

As we continue to enter new markets, grow within our existing markets and reach a broader population, we continue to invest in our operations, talent and technology capabilities to support that growth.” ” Jill Howe, Lineage Cell Therapeutics. .” ” Patrick Genestin, 1910 Genetics .

Life Science 105

Life Science Genetics Business Development Marketing 105

Drug Channels

AUGUST 13, 2021

Today’s guest post comes from Stacey Little, Senior Vice President of Business Development and Marketing at AssistRx. Stacey discusses how a patient support vendor can help specialty pharmacy patients attain prior authorizations and access critical therapies.

Branding 75

Branding Pharmacy Business Development Manufacturing 75

pharmaphorum

SEPTEMBER 30, 2021

The $180-per-share deal – if completed – will give Merck a pair of blockbuster drug candidates, one of which is already on the market, and help to reduce its reliance on $14.4 billion immuno-oncology blockbuster Keytruda (pembrolizumab).

Sales 117

Sales Marketing Pharma Companies Business Development 117